Key Highlights
- Melrose Industries (LSE:MRO) rose about 1.7% to around 485p on Friday 16 October 2026, extending a strong week on the FTSE 100.
- The shares gained about 9.1% over the week after GKN Aerospace agreed a $125m settlement over its Garden Grove, California chemical incident.
- The settlement includes a claims programme of up to $100m, $15m of civil penalties and $10m for emergency services claims, subject to court approval.
- GKN plans a phased return to full capacity at the site in the fourth quarter, subject to approvals.
- A trading update on 18 November 2026 is the next key event.
Why Melrose Was in Focus on 16 October 2026
Melrose Industries (LSE:MRO) added roughly 1.7% to close at around 485p on Friday 16 October 2026, rounding off a week in which the aerospace engineering group's shares climbed about 9.1%. The gains came as the FTSE 100 rose 0.38% to 10,881.90 and posted a 3.1% weekly advance, its best week in around six months.
There was no new announcement from Melrose on Friday. Instead, investors continued to respond to news earlier in the week that removed a major uncertainty. The broader market backdrop also helped: money rotated out of AI and chip stocks after a global sell-off and into UK industrial, defence and defensive names, with defence-linked stocks such as Babcock and BAE Systems leading the index. Melrose's GKN Aerospace business has significant defence exposure, which put it in a favourable part of the market.
The Garden Grove Settlement
On Tuesday 13 October 2026, Melrose Industries (LSE:MRO) announced that GKN Aerospace had agreed a $125m settlement with California authorities over a chemical incident at its Garden Grove facility in May. The incident involved a methyl methacrylate tank and led to the evacuation of around 50,000 people. The Orange County District Attorney's office had already closed its criminal investigation in August without bringing charges.
The settlement has three parts: a claims programme of up to $100m for eligible residents and businesses, $15m in civil enforcement penalties and $10m covering claims received so far from emergency services and other authorities. It requires court approval, and the claims programme is expected to open within days of that approval. Melrose said it remains in mediation over pending civil class action lawsuits and is reviewing its insurance position.
GKN said it had made significant progress preparing the facility to resume full operations and plans a phased return to full capacity in the fourth quarter, subject to regulatory approval. Investors welcomed the clarity: the shares rose about 4.5% to near 470p on the day of the announcement.
What Melrose Does
Melrose Industries (LSE:MRO) owns GKN Aerospace, one of the world's leading tier-one aerospace suppliers. It operates through two main divisions: Engines, which makes components for aircraft engines and benefits from long-term revenue-sharing partnerships, and Structures, which produces airframe components and electrical wiring systems. In 2025, civil aerospace accounted for about 71% of sales and defence about 29%.
Financial Performance and Outlook
In 2025, Melrose grew revenue by 8% to £3.59bn and adjusted operating profit by 23% to £647m, with the Engines division leading the way. For 2026, it guided to revenue of £3.75bn to £3.95bn and adjusted operating profit of £700m to £750m, and it reiterated 2029 targets of around £5bn of revenue and at least £1.2bn of adjusted operating profit.
The Garden Grove incident reduced first-half revenue by £16m and adjusted operating profit by £9m. Melrose paused its planned £175m share buyback for 2026 until the financial impact became clearer. Before this week's rally, the shares were down about 11% over six months and 25% over a year, which helps explain the strength of the rebound once the settlement removed a major overhang.
Risks to Watch
Court approval of the settlement is not yet secured, and the outcome of the class action mediation and insurance recoveries remains uncertain. The phased restart of Garden Grove depends on regulatory sign-off. More broadly, Melrose is exposed to the civil aerospace supply chain, where engine and airframe production rates at Airbus and Boeing, supply bottlenecks and cost inflation can affect margins and cash flow.
What Investors Are Watching Next
The next milestone for Melrose Industries (LSE:MRO) is its trading update on 18 November 2026, covering the four months to 31 October. Investors will look for an update on Garden Grove costs, the restart timetable, full-year guidance and whether the paused £175m buyback can resume. Court approval of the settlement, any resolution of class actions, aircraft production trends and the UK Budget on 28 October will also influence the shares on the FTSE 100.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...